Mona Ridderheim

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients
    Mona Ridderheim
    Department of Oncology, University Hospital, 221 85 Lund, Sweden
    Support Care Cancer 11:371-7. 2003
  2. ncbi Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
    Per Rosenberg
    Department of Gynecological Oncology, University Hospital, Linkoping, Sweden
    Acta Oncol 41:418-24. 2002
  3. ncbi Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study
    Bo Gronlund
    Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Cancer 103:1388-96. 2005

Collaborators

Detail Information

Publications3

  1. ncbi Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients
    Mona Ridderheim
    Department of Oncology, University Hospital, 221 85 Lund, Sweden
    Support Care Cancer 11:371-7. 2003
    ..The aim of this study was to examine the efficacy and safety of a new digitized, controlled, scalp-cooling system to prevent chemotherapy-induced alopecia...
  2. ncbi Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
    Per Rosenberg
    Department of Gynecological Oncology, University Hospital, Linkoping, Sweden
    Acta Oncol 41:418-24. 2002
    ..Weekly paclitaxel at a dose of 67 mg/m2/week was found to have a better safety profile and seemed to be as effective as the equivalently dosed schedule every 3 weeks. Intravenous steroids are a safe alternative to oral steroids...
  3. ncbi Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study
    Bo Gronlund
    Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Cancer 103:1388-96. 2005
    ..00 mg/m2 on Days 1-5) and increasing doses of oral etoposide (50 mg, 75 mg, and 100 mg on Days 6-12 or Days 6-19) in patients with recurrent ovarian carcinoma...